Kohls Corp. (KSS) Tops Q4 EPS by 1c, Offers Weak Q1 and FY12 Guidance, Boosts Dividend 28%
Get Alerts KSS Hot Sheet
Price: $24.58 -0.81%
EPS Growth %: -110.0%
Financial Fact:
Depreciation and amortization: 232M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -110.0%
Financial Fact:
Depreciation and amortization: 232M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Kohls Corp. (NYSE: KSS) reported Q4 EPS of $1.81, $0.01 better than the analyst estimate of $1.80. Revenue for the quarter came in at $6.02 billion versus the consensus estimate of $6.06 billion.
Kohls Corp. sees FY2012 EPS of $4.75, versus the consensus of $4.95. Kohls Corp. sees FY2012 revenue growth of 4.5%.
Kohls Corp. sees Q1 2012 EPS of $0.60, versus the consensus of $0.77. Kohls Corp. sees Q1 2012 revenue growth of 3%.
On February 22, 2012, Kohl's Board of Directors declared a quarterly cash dividend of $0.32 per share of Kohl’s common stock; a $0.07 per share and 28% increase over previous quarterly dividends. The dividend is payable March 28, 2012 to shareholders of record at the close of business on March 7, 2012.
For earnings history and earnings-related data on Kohls Corp. (KSS) click here.
Kohls Corp. sees FY2012 EPS of $4.75, versus the consensus of $4.95. Kohls Corp. sees FY2012 revenue growth of 4.5%.
Kohls Corp. sees Q1 2012 EPS of $0.60, versus the consensus of $0.77. Kohls Corp. sees Q1 2012 revenue growth of 3%.
On February 22, 2012, Kohl's Board of Directors declared a quarterly cash dividend of $0.32 per share of Kohl’s common stock; a $0.07 per share and 28% increase over previous quarterly dividends. The dividend is payable March 28, 2012 to shareholders of record at the close of business on March 7, 2012.
For earnings history and earnings-related data on Kohls Corp. (KSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Hubbell Inc. (HUBB) Raises Quarterly Dividend 7% to $1.52; 1.4% Yield
- BioNTech and Bristol Myers Squibb report Phase 2 data for pumitamig in NSCLC
Create E-mail Alert Related Categories
Dividends, Earnings, Guidance, Hot GuidanceRelated Entities
Dividend, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share